HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antti Jylhä Selected Research

Antti Jylhä Research Topics

Disease

3Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2020
3Inflammation (Inflammations)
12/2021 - 01/2019
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 01/2020
2Heart Failure
09/2021 - 01/2020
2Coronary Disease (Coronary Heart Disease)
01/2020 - 01/2020
2Glaucoma
01/2018 - 01/2018
1Myocardial Infarction
01/2022
1Stroke (Strokes)
01/2022
1Atherosclerosis
12/2021
1Type 2 Diabetes Mellitus (MODY)
12/2021
1Atrial Fibrillation
09/2021
1Rheumatoid Arthritis
09/2021
1Ovarian Neoplasms (Ovarian Cancer)
04/2021
1Neoplasms (Cancer)
04/2021
1Dyslipidemias (Dyslipidemia)
01/2020
1Atherosclerotic Plaque (Atheroma)
01/2020
1Necrosis
01/2020
1Strabismus (Squint)
01/2019
1Hyperemia
01/2018
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2018
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2018
1Prostatic Neoplasms (Prostate Cancer)
01/2018
1Retinal Vein Occlusion
01/2018
1Retinopathy of Prematurity (Retrolental Fibroplasia)
01/2018
1Dry Eye Syndromes (Dry Eye Syndrome)
01/2018
1Hypoxia (Hypoxemia)
01/2018
1Retinal Degeneration
01/2017

Drug/Important Bio-Agent (IBA)

6CeramidesIBA
01/2022 - 01/2020
4LipidsIBA
12/2021 - 01/2020
4Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2017
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2018
2Phosphatidylcholines (Phosphatidylcholine)IBA
12/2021 - 01/2020
2Phospholipids (Phosphatides)FDA LinkGeneric
01/2020 - 01/2020
2Pharmaceutical PreparationsIBA
01/2018 - 01/2018
1omega-Chloroacetophenone (Mace)IBA
01/2022
1CholesterolIBA
01/2022
1Lipoproteins (Lipoprotein)IBA
12/2021
1Apolipoprotein C-IIIIBA
12/2021
1CoffeeFDA Link
09/2021
1AntigensIBA
04/2021
1Interleukin-6 (Interleukin 6)IBA
01/2020
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2020
1LDL CholesterolIBA
01/2020
1C-Reactive ProteinIBA
01/2020
1darapladibIBA
01/2020
11-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
01/2020
1tear proteinsIBA
01/2019
1FilaminsIBA
01/2018
1Crystallins (Crystallin)IBA
01/2018
1Oxygen (Dioxygen)IBA
01/2018
1SteroidsIBA
01/2018
1Latanoprost (Xalatan)FDA Link
01/2018
1ProteomeIBA
01/2018
1Nonmuscle Myosin Type IIAIBA
01/2018
1tafluprostIBA
01/2018
1Fluorometholone (FML)FDA Link
01/2018

Therapy/Procedure

1Therapeutics
01/2020
1Refractive Surgical Procedures
01/2019
1Castration
01/2018